Filing Flows › GSK (GSK) › Q1 2025
GSK (GSK) Q1 2025 earnings results (first quarter 2025)
6-K filed Apr 30, 2025
GSK (GSK) reported revenue of $7.5B for the first quarter 2025 (Q1 2025), +2% from a year earlier. Operating margin was 29.5%, net earnings $1.6B (21.6% of revenue).
GSK, Q1 2025: revenue $7.5B (+2% year over year), operating margin 29.5%, net earnings $1.6B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.5B | — | +2% |
| Gross profit | $5.6B | — | +3% |
| Operating profit | $2.2B | — | +49% |
| Net earnings | $1.6B | — | +55% |
| Operating cash flow | $1.3B | — | 81× |
What changed
Revenue was £7.5B in Q1 2025, up 2% year over year. HIV was the largest line at 23% of revenue.
Gross margin was 74.2%, up 1.0 points from a year earlier. Operating profit was £2.2B, a 29.5% margin (up 9.2 points year over year). Of the extra revenue versus a year earlier, 475% reached operating profit, above the 20% margin then. Operating expenses fell 14% while revenue rose 2%. Net earnings were £1.6B, up 55% year over year. The effective tax rate was 15.9%.
Operating cash flow was £1.3B (up 8031% year over year), 73% of net income including minority interests. Working capital and other items used £0.47B.
Questions
What was GSK's revenue in the first quarter 2025?
GSK (GSK) reported revenue of $7.5B for the first quarter 2025 (Q1 2025), +2% from a year earlier.
Was GSK profitable in the first quarter 2025?
Operating profit was $2.2B (29.5% of revenue) and net earnings $1.6B.
Source: GSK 6-K on SEC EDGAR.